• Emil Pot, Co-Founder and CEO of Allero Therapeutics

  • Oct 20 2021
  • Length: 49 mins
  • Podcast

Emil Pot, Co-Founder and CEO of Allero Therapeutics

Listen for free

View show details

  • Summary

  • As something that affects as much as 10% of the global population, food allergies are an important topic of discussion in this value-packed episode of High Potential Start-ups.

    In episode 3, guest speaker Emil Pot, Co-Founder and CEO of Allero Therapeutics, and host Nick Ross, Co-Founder of Cavenagh Health, delve into numerous talking points surrounding everything from food-related immune disorders to running a successful biotech company. 

    Emil’s career started in law, but his keen interest in science quickly led to biotech becoming the central point of his career.

    Now, Emil and his team at Allero Therapeutics have developed an innovative solution to treating autoimmune disorders like celiac disease.

    Get in touch with Emil.

    Get in Touch with Nick.
    Show More Show Less
Show More Show Less

What listeners say about Emil Pot, Co-Founder and CEO of Allero Therapeutics

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.